4 Healthcare Stocks for Investors to Check Out

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

GlaxoSmithKline (NYSE:GSK): Closing price $44.28

On Wednesday, GlaxoSmithKline and Theravance (NASDAQ:THRX) reported the submission of a regulatory application in the European Union for the investigational once-daily LAMA/LABA combination medicine, UMEC/VI, for patients suffering from chronic obstructive pulmonary disease . On December 18th, the firm announced the submission of a regulatory application with the FDA  for UMEC/VI.


More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business